Alida Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.52M

  • Investors
  • 6

Alida Biosciences General Information

Description

Operator of a biotechnology company intended to create new technologies for the advancement of human health. The company creates new technologies in RNA biology to improve human health, which helps to discover new drugs and therapeutics, enabling patients to receive medical treatments and diagnostic assays along with effective therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 407
  • San Diego, CA 92121
  • United States
+1 (720)
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 11535 Sorrento Valley Road
  • Suite 407
  • San Diego, CA 92121
  • United States
+1 (720)

Alida Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alida Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Early Stage VC (Series A) 12-Jun-2024 $7.52M Completed Generating Revenue
10. Grant 01-Jan-2024 Completed Product Development
9. Grant 01-Jan-2024 Completed Product Development
8. Grant 01-Aug-2023 Completed Product Development
7. Grant 01-Apr-2023 Completed Product Development
6. Grant 01-Jan-2023 Completed Startup
5. Grant 15-Jul-2022 Completed Startup
4. Grant 13-Jun-2022 Completed Startup
3. Seed Round 19-May-2022 $4M $5.11M Completed Startup
2. Seed Round 21-Sep-2021 $1.11M $1.11M Completed Startup
To view Alida Biosciences’s complete valuation and funding history, request access »

Alida Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2
Seed
To view Alida Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Alida Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to create new technologies for the advancement of human health. The company
Diagnostic Equipment
San Diego, CA
20 As of 2026

Richmond, CA

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alida Biosciences Competitors (36)

One of Alida Biosciences’s 36 competitors is ProMab Biotechnologies, a Private Equity-Backed company based in Richmond, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProMab Biotechnologies Private Equity-Backed Richmond, CA
etherna Formerly VC-backed Niel, Belgium
Kymera Therapeutics Formerly VC-backed Watertown, MA
Relay Therapeutics Formerly VC-backed Cambridge, MA
Triumvira Venture Capital-Backed Hamilton, Canada
You’re viewing 5 of 36 competitors. Get the full list »

Alida Biosciences Patents

Alida Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023384167-A1 Chromatin profiling compositions and methods Pending 23-Nov-2022
EP-4623079-A1 Chromatin profiling compositions and methods Pending 23-Nov-2022
JP-2025539357-A Chromatin profiling compositions and methods Pending 23-Nov-2022
US-12571040-B2 Chromatin profiling compositions and methods Active 23-Nov-2022
US-20250277266-A1 Chromatin profiling compositions and methods Active 23-Nov-2022 C12Q1/6874
To view Alida Biosciences’s complete patent history, request access »

Alida Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alida Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Genoa Ventures Venture Capital Minority
National Institutes of Health Government
Vertical Venture Partners Venture Capital Minority
FusionX Ventures Venture Capital Minority
General Inception Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Alida Biosciences FAQs

  • When was Alida Biosciences founded?

    Alida Biosciences was founded in 2020.

  • Where is Alida Biosciences headquartered?

    Alida Biosciences is headquartered in San Diego, CA.

  • What is the size of Alida Biosciences?

    Alida Biosciences has 20 total employees.

  • What industry is Alida Biosciences in?

    Alida Biosciences’s primary industry is Diagnostic Equipment.

  • Is Alida Biosciences a private or public company?

    Alida Biosciences is a Private company.

  • What is Alida Biosciences’s current revenue?

    The current revenue for Alida Biosciences is .

  • How much funding has Alida Biosciences raised over time?

    Alida Biosciences has raised $12.6M.

  • Who are Alida Biosciences’s investors?

    Genoa Ventures, National Institutes of Health, Vertical Venture Partners, FusionX Ventures, and General Inception are 5 of 6 investors who have invested in Alida Biosciences.

  • Who are Alida Biosciences’s competitors?

    ProMab Biotechnologies, etherna, Kymera Therapeutics, Relay Therapeutics, and Triumvira are some of the 36 competitors of Alida Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process